Anti-c-myc RNAi-Based Onconanotherapeutics
Open Access
- 15 December 2020
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 8 (12) , 612
Abstract
Overexpression of the c-myc proto-oncogene features prominently in most human cancers. Early studies established that inhibiting the expression of oncogenic c-myc, produced potent anti-cancer effects. This gave rise to the notion that an appropriate c-myc silencing agent might provide a broadly applicable and more effective form of cancer treatment than is currently available. The endogenous mechanism of RNA interference (RNAi), through which small RNA molecules induce gene silencing by binding to complementary mRNA transcripts, represents an attractive avenue for c-myc inhibition. However, the development of a clinically viable, anti-c-myc RNAi-based platform is largely dependent upon the design of an appropriate carrier of the effector nucleic acids. To date, organic and inorganic nanoparticles were assessed both in vitro and in vivo, as carriers of small interfering RNA (siRNA), DICER-substrate siRNA (DsiRNA), and short hairpin RNA (shRNA) expression plasmids, directed against the c-myc oncogene. We review here the various anti-c-myc RNAi-based nanosystems that have come to the fore, especially between 2005 and 2020.Keywords
Funding Information
- National Research Foundation of South Africa (113850 and 120455)
This publication has 114 references indexed in Scilit:
- Systemic Delivery of siRNA via LCP Nanoparticle Efficiently Inhibits Lung MetastasisMolecular Therapy, 2012
- MYC on the Path to CancerCell, 2012
- Elimination Pathways of Systemically Delivered siRNAMolecular Therapy, 2011
- Nanoparticles Targeted With NGR Motif Deliver c-myc siRNA and Doxorubicin for Anticancer TherapyMolecular Therapy, 2010
- Efficient Oncogene Silencing and Metastasis Inhibition via Systemic Delivery of siRNAMolecular Therapy, 2008
- Inhibition of c‐Myc activity by ribosomal protein L11The EMBO Journal, 2007
- Global mapping of c-Myc binding sites and target gene networks in human B cellsProceedings of the National Academy of Sciences, 2006
- eIF4E is a central node of an RNA regulon that governs cellular proliferationJournal of Cell Biology, 2006
- Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacyNature Biotechnology, 2004
- The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic miceNature, 1985